Orexigen (OREX)'s Failure to Keep a Lid on it Prompts the FDA to Force a Second Study
After Turning Down Sanofi (SAN.PA) Gig, Takeda (TKPYY) COO Gets Promoted to CEO
Bristol-Myers Squibb (BMY) Bets $975 Million on Bavarian Nordic (BAVA.CO)'s Prostate Cancer Vaccine
Novartis AG (NVS) Will Move Past Scandal While Hunting for More M&A in the $2-5 Billion Range, Says CEO
Malin, Formed by Ex-Elan (ELN) Execs, Eye Up to $365 Million in Biotech IPO
Baxter International (BAX) Snaps Up German Biopharma for $225 Million
Poll Result for Best Hair In BioPharma Crown Receptos (RCPT)'s Hasnain King
Valeant (VRX) Starts Chopping Dendreon (DNDN) Employees
Backed By a Genentech (RHHBY) Alum, NGM Looks Like it Could be the Next Biotech IPO
With Two Ex-Elan (ELN) Execs at the Helm, Bay Area's Serenus Nabs $43 Million
CALBIO15: Johnson & Johnson (JNJ) Unveils New Innovation Center, Looks to Spark Creative Revolution in the Bay: Exec
A Peek Inside Ex-Dendreon (DNDN) CEO, Amgen (AMGN) Scientists' New Startup Alpine Immune Sciences
Genentech (RHHBY)'s Controversial Distribution Move Deemed a Failure: Survey
SoCal Biotech AtheroNova (AHRO) and its Subsidiary File for Chapter 11
Teva (TEVA) Sells Plant, 25 Drugs to G&W Laboratories; 280 Jobs Salvaged
Sun Pharma (SUNPHARMA.NS) Snaps Up GlaxoSmithKline (GSK)'s Opiates Business
CALBIO15: Genomics Need to Bridge Gap Between Medicine and Science, Says Panel
CALBIO2015: "Health is the New Asset Class," Says Former Pfizer (PFE) Exec, With Daily Breakthroughs Coloring Investment
See All News >
//-->